Bayer Stock
Investor Information
Bayer stock could not escape the turbulence on the international stock markets in the first quarter, closing on March 31, 2008, at €50.76, down 18.8 percent from the closing price on December 31, 2007.
The DAX lost 19.0 percent in the same period, closing at 6,535 points on March 31. The European reference index Euro Stoxx 50 also fell by 17.4 percent from the beginning of the year, finishing the quarter at 5,362 points.
The DAX lost 19.0 percent in the same period, closing at 6,535 points on March 31. The European reference index Euro Stoxx 50 also fell by 17.4 percent from the beginning of the year, finishing the quarter at 5,362 points.
| Bayer Stock Key Data | 1st Quarter 2007 | 1st Quarter 2008 | Full Year 2007 | ||
| High for the period | € | 47.84 | 65.68 | 62.53 | |
| Low for the period | € | 40.20 | 45.90 | 40.20 | |
| Average daily share turnover on German stock exchanges | million | 5.5 | 7.4 | 5.7 | |
| March 31, 2007 | March 31, 2008 | Dec. 31, 2007 | Change March 31, 2008/ Dec. 31, 2007 % | ||
| Share price | € | 47.84 | 50.76 | 62.53 | -18.8 |
| Market capitalization | € million | 36,566 | 38,798 | 47,794 | -18.8 |
| Stockholders’ equity | € million | 15,906 | 17,605 | 16,821 | +4.7 |
| Number of shares entitled to the dividend | million | 764.34 | 764.34 | 764.34 | |
| DAX | 6,917 | 6,535 | 8,067 | -19.0 |
XETRA closing price; source: Bloomberg
Performance over the Past Twelve Months
(indexed; 100 = Xetra closing price on March 31, 2007)

Earnings per share according to IFRS are affected by the purchase price allocation for Schering, Berlin, Germany, and other special factors. To enhance comparability, we also determine core net income from continuing operations after elimination of the amortization of intangible assets, asset write-downs (including any impairment losses), special items in EBITDA including the related tax effects, and one-time tax income or expense.
The calculation of earnings per share in accordance with IFRS is explained in the notes to the consolidated financial statements. Adjusted core net income, core earnings per share and core EBIT are not defined in the International Financial Reporting Standards. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
The calculation of earnings per share in accordance with IFRS is explained in the notes to the consolidated financial statements. Adjusted core net income, core earnings per share and core EBIT are not defined in the International Financial Reporting Standards. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
| Calculation of Core EBIT and Core Earnings per Share | 1st Quarter 2007 | 1st Quarter 2008 |
| € million | ||
| EBIT as per income statement | 1,175 | 1,343 |
| Amortization and write-downs of intangible assets | 293 | 407 |
| Write-downs of property, plant and equipment | 24 | 31 |
| Special items (other than write-downs) | 216 | 130 |
| Core EBIT | 1,708 | 1,911 |
| Non-operating result (as per income statement) | (218) | (275) |
| Income taxes (as per income statement) | (301) | (306) |
| Tax adjustment | (177) | (173) |
| Income after taxes attributable to minority interest (as per income statement) | (1) | 0 |
| Core net income from continuing operations | 1,011 | 1,157 |
| Financing expenses for the mandatory convertible bond, net of tax effects | 24 | 28 |
| Adjusted core net income | 1,035 | 1,185 |
| Shares | ||
| Weighted average number of issued ordinary shares | 764,341,920 | 764,341,920 |
| Potential shares to be issued upon conversion of the mandatory convertible bond | 59,523,810 | 59,582,699 |
| Adjusted weighted average total number of issued and potential ordinary shares | 823,865,730 | 823,924,619 |
| Core earnings per share from continuing operations (€) | 1.26 | 1.44 |

Overview of Sales, Earnings and Financial Position
Bayer Links
Investor Relations

Bookmark this page
E-mail this page
Advanced Search

